LoadingLoadingLoadingThe quick read
Latest quote·Oct 14
No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNeither. Annovis Bio Inc (ANVS) insiders filed no open-market purchases or sales in the 90 days to Oct 16, 2026, according to SEC Form 4 filings.
None. No member of Congress disclosed a ANVS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
This summary uses filings available on Oct 16, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net buying.
Buys (1)
Hoffman Michael B
$143K
bought
No tracked top-trader positions in ANVS right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Aug 14, 2026
Period ending
Jun 30, 2026
Adjusted EPS
-$0.46 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 14, 2026 | -$0.40 / -$0.46Yahoo Finance | +13.04% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 15, 2026 | -$0.63 / -$0.35Yahoo Finance | -80.00% miss | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 13, 2026 | -$0.39 / -$0.30Yahoo Finance | -30.00% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 12, 2025 | -$0.37 / -$0.37Yahoo Finance | +0.00% in line | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 12, 2025 | -$0.32 / -$0.39Alpha Vantage | +17.95% beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 13, 2025 | -$0.32 / -$0.80Alpha Vantage | +60.00% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 21, 2025 | -$0.43 / -$0.20Alpha Vantage | -115.00% miss | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 8, 2024 | -$0.97 / -$0.60Alpha Vantage | -61.67% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
This company is running thin margins.
Valuation
Quality
Growth
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
